{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:23:49Z","timestamp":1790936629311,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.pbb.2007.04.007","type":"journal-article","created":{"date-parts":[[2007,4,17]],"date-time":"2007-04-17T15:23:32Z","timestamp":1176823412000},"page":"115-121","source":"Crossref","is-referenced-by-count":24,"title":["Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats"],"prefix":"10.1016","volume":"87","author":[{"given":"Darakhshan Jabeen","family":"Haleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noreen","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abdul","family":"Haleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2007.04.007_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1476-5381.1996.tb15419.x","article-title":"Prevention by (+\/\u2212)-8-hydroxy-2-(di-n propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol","volume":"118","author":"Anderson","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2007.04.007_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00427514","article-title":"Effects of drugs influencing central serotonin mechanism on metamphetamine-induced stereotypic behavior in the rat","volume":"64","author":"Balsara,","year":"1979","journal-title":"Psychopharmacology"},{"issue":"Supp 3","key":"10.1016\/j.pbb.2007.04.007_bib3","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1097\/00004714-199006001-00004","article-title":"Differential effects of gepirone on presynaptic ad postsynaptic serotonin receptors: single cell recording studies","volume":"10","author":"Blier","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2007.04.007_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01643-8","article-title":"Is there a role of 5-HT-1A agonists in the treatment of depression","volume":"53","author":"Blier","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib5","first-page":"5","article-title":"Tardive dyskinesia: pathophysiology and animal models","volume":"61","author":"Casey","year":"2000","journal-title":"J Clin Psychiatry,"},{"issue":"2","key":"10.1016\/j.pbb.2007.04.007_bib6","first-page":"614","article-title":"Amphetamine levels in brain microdialysate, caudate\/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects","volume":"274","author":"Clausing","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.04.007_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s002130050095","article-title":"Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol","volume":"127","author":"Egan","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2007.04.007_bib8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/schbul\/23.4.583","article-title":"Treatment of tardive dyskinesia","volume":"23","author":"Egan","year":"1997","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pbb.2007.04.007_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/BF00441962","article-title":"Rats administered chronic neuroleptics develop oral movements which are similar in forms to those in humans with tardive dyskinesia","volume":"98","author":"Ellison","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2007.04.007_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0306-4522(99)00211-0","article-title":"Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin-1A receptors and blockade of alpha-2-adrenergic receptors underlie its activation","volume":"93","author":"Gobert","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2007.04.007_bib11","doi-asserted-by":"crossref","first-page":"PL221","DOI":"10.1016\/0024-3205(92)90554-3","article-title":"Sex differences in neurochemical and behavioral effects of 8-hydroxy-2-di-n-propylamino tetralin","volume":"50","author":"Haleem","year":"1992","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.pbb.2007.04.007_bib12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0278-5846(03)00074-5","article-title":"Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats","volume":"27","author":"Haleem","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib13","first-page":"3354","article-title":"Differences in the effects of haloperidol and clozapine on rat brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats","volume":"8","author":"Haleem","year":"2002","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.pbb.2007.04.007_bib14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.pnpbp.2004.08.003","article-title":"Somatodendritic and postsynaptic 5-HT-1A receptors in the attenuation of haloperidol-induced catalepsy","volume":"28","author":"Haleem","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/1389450043345173","article-title":"Psychosocial conditions and the efficacy of clinically available anxiolytics","volume":"5","author":"Haller","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pbb.2007.04.007_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF00451692","article-title":"Regional differences in the induction of behavioral supersensitivity by prolonged treatment with a typical neuroleptic","volume":"98","author":"Halperin","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2007.04.007_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0006-8993(99)02346-X","article-title":"The effect of serotonin (1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens","volume":"858","author":"Ichikawa","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2007.04.007_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiperazine is a potent, partial agonist at the human 5-HT-1A receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2007.04.007_bib19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1176\/ajp.153.4.466","article-title":"Serotonin dopamine interaction and its relevance to schizophrenia","volume":"153","author":"Kapur","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3928\/0279-3695-20020701-11","article-title":"The use of buspirone in primary care","volume":"40","author":"Khouzam","year":"2002","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/j.pbb.2007.04.007_bib21","first-page":"148","article-title":"Animal models of tardive dyskinesia\u2014a review","volume":"45","author":"Kulkarni","year":"2001","journal-title":"Indian J Physiol Pharmacol."},{"key":"10.1016\/j.pbb.2007.04.007_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0006-3223(01)01202-1","article-title":"5-HT-1A receptor dysfunctions in female patients with schizophrenia","volume":"50","author":"Lee","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1460-9568.2002.01944.x","article-title":"Subchronic treatment with classical but not atypical antipsychotic produced morphological changes in rat nigrostriatal dopaminergic neurons directly related to early onset vacuous chewing","volume":"15","author":"Marchese","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2007.04.007_bib24","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT-2C) receptors tonic ally inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2007.04.007_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0014-2999(01)01284-5","article-title":"Effect of 5-HT-1A and 5-HT-2A\/2C receptor modulation on neuroleptic-induced vacuous chewing movements","volume":"428","author":"Naidu","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2007.04.007_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bjp.0704717","article-title":"Carvediol attenuates neuroleptic-induced orofacial dyskinesia, possible antioxidant mechanism","volume":"136","author":"Naidu","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2007.04.007_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ptr.1823","article-title":"Effects of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunctions","volume":"20","author":"Naidu","year":"2006","journal-title":"Phytother Res"},{"key":"10.1016\/j.pbb.2007.04.007_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0028-3908(95)00170-0","article-title":"Clozapine is a partial agonist at cloned human serotonin 5-HT-1A receptors","volume":"35","author":"Newman-Tancredi","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2007.04.007_bib29","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1046\/j.1471-4159.1999.0722022.x","article-title":"Effect of acute and chronic administration of the serotonin-1A agonist buspirone on serotonin synthesis in rat brain","volume":"72","author":"Okazawa","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2007.04.007_bib30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0006-3223(85)90194-5","article-title":"Selective interaction of novel anxiolytics with 5-hydroxytryptamine 1A receptors","volume":"20","author":"Peroutka","year":"1985","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib31","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0006-8993(94)90495-2","article-title":"Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro","volume":"654","author":"Pessia","year":"1994","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.pbb.2007.04.007_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0091-3057(93)90296-6","article-title":"Time sampling observation procedure for studying interaction between d-amphetamine and selective dopamine receptor antagonists in the rat","volume":"44","author":"Petry","year":"1993","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2007.04.007_bib33","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0278-5846(99)00074-3","article-title":"Effects of buspirone on an animal model of tardive dyskinesia","volume":"23","author":"Queiroz","year":"1999","journal-title":"Prog. Neuropsychopharmacol. Biol Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pnpbp.2005.08.014","article-title":"The effect of chronic administration of sarizotan, 5-HT-1A agonist\/D3\/D4 ligand on the haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia","volume":"30","author":"Rosengarten","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiat."},{"key":"10.1016\/j.pbb.2007.04.007_bib35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/j.1440-1614.2000.00737.x","article-title":"The current status of tardive dyskinesia","volume":"34","author":"Sachdev","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/00207458808991596","article-title":"Serotonin in involuntary movement disorders","volume":"42","author":"Sandyk","year":"1988","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pbb.2007.04.007_bib37","first-page":"753","article-title":"Motor effects of buspirone: relationship with dopamine and serotonin in the striatum","volume":"15","author":"Shireen","year":"2005","journal-title":"J Coll. Physician Surg Pak"},{"key":"10.1016\/j.pbb.2007.04.007_bib38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF02247127","article-title":"Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia; a study in three rat strains","volume":"102","author":"Tamminga","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2007.04.007_bib39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archpsyc.59.6.514","article-title":"Brain serotonin 5-HT-1A receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635","volume":"59","author":"Tauscher","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(84)90714-3","article-title":"The involvement of subtypes of 5-HT receptors and of catecholaminergic system in the behavioral response to 8-OH-DPAT in the rat","volume":"106","author":"Tricklebank","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2007.04.007_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0028-3908(92)90099-B","article-title":"Influence of repeated treatment with buspirone on 5-hydroxytryptamine and dopamine synthesis","volume":"31","author":"Tunnicliff","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2007.04.007_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02244220","article-title":"Spontaneous orofacial movements-induced in rodents by very long term-neuroleptic administration: phenomenology, pathophysiology and putative relationship with tardive dyskinesia","volume":"101","author":"Waddington","year":"1990","journal-title":"Psychopharmacology (Berl),"},{"key":"10.1016\/j.pbb.2007.04.007_bib43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1176\/ajp.153.7.951","article-title":"Time required for initial improvement during clozapine treatment of refractory schizophrenia","volume":"153","author":"Wilson","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2007.04.007_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(97)01551-5","article-title":"Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia","volume":"788","author":"Wright","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2007.04.007_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0014-2999(88)90205-1","article-title":"The behavioral effects of 8-OH-DPAT in mice","volume":"154","author":"Yamada","year":"1988","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305707001293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305707001293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T16:49:10Z","timestamp":1628786950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305707001293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0091305707001293"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2007.04.007","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}